about
Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variantEndothelial cell control of thrombosisShould dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trialsColchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trialsAdiponectin and cardiovascular disease: state of the art?Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis.Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages.Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteriesEnhanced relaxation of porcine coronary arteries after acute exposure to a physiological level of 17beta-estradiol involves non-genomic mechanisms and the cyclic AMP cascade.The essential autophagy gene ATG7 modulates organ fibrosis via regulation of endothelial-to-mesenchymal transition.Managing cardiometabolic risk in primary care: summary of the 2011 consensus statementBRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failureEndothelial-specific deletion of autophagy-related 7 (ATG7) attenuates arterial thrombosis in mice.Should C-reactive protein be a target of therapy?Should A1C targets be individualized for all people with diabetes? Arguments for and against.Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality.DNA damage repair and cardiovascular diseases.Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).Benefits of modest weight loss on the management of type 2 diabetes mellitus.Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.Obesity and atherosclerosis: mechanistic insights.Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.Axillary versus innominate artery cannulation for antegrade cerebral perfusion in aortic surgery: design of the Aortic Surgery Cerebral Protection Evaluation (ACE) CardioLink-3 randomised trial.Randomised trial of mitral valve repair with leaflet resection versus leaflet preservation on functional mitral stenosis (The CAMRA CardioLink-2 Trial).Blood Pressure Management in Patients with Diabetes: Insights From the Diabetes Mellitus Status in Canada Survey.Cardiovascular inflammation is reduced with methotrexate in diabetes.Dual antiplatelet therapy use by Canadian cardiac surgeons.Investigation of TGFβ1-Induced Long Noncoding RNAs in Endothelial CellsInvestigation of novel LPS-induced differentially expressed long non-coding RNAs in endothelial cells.Role of Cl- currents in rat aortic smooth muscle activation by prostaglandin F2 alpha.Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial.BRCA1 shields vascular smooth muscle cells from oxidative stress.Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer.Effects of ezetimibe add-on to statin therapy on adipokine production in patients with metabolic syndrome and stable vascular disease.Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.Type 2 diabetes mellitus management in Canada: is it improving?Increased myofibrillar protein phosphatase-1 activity impairs rat aortic smooth muscle activation after hypoxia.
P50
Q24294275-632BFECD-4A4D-41AD-81B4-3627F63C55B7Q26781779-5E4A3AE7-AC9F-4F5C-A1A8-330874246BEBQ26782970-9343B2C7-5E08-4C0B-B00A-0F4FB6CCD624Q26796341-DA695416-144F-41C0-B00F-49E6020BE1D4Q30358456-7946E437-C98C-4814-9778-89A64F2C82E7Q30846870-25200D02-1BAB-48D9-92C6-67D902A40DE9Q33994044-BF8A37F5-9B1B-45D5-80EE-6299FFDBBA85Q34150591-AC52247E-79D4-4C62-966E-3118514C7C11Q35042065-3F3BB531-9553-408A-9481-8503A75DEA5EQ35042165-5EAF84CF-8A76-4A71-8C35-72DD2A91A5E0Q35048942-619395E1-48EB-4231-8C58-3BDCB22D47EEQ35886415-61AA1BDC-6C5F-4D07-8424-A33AAC6D48C0Q35886872-0D2C7EA7-5EA0-4740-A000-345459037B47Q36344022-6283188A-CFDF-41D2-A5FE-4991F2FE617DQ36783729-F759B291-9426-480D-9FC0-034CD5DB77E8Q36783760-94C0E0F5-0653-45C6-9DAA-D4B361910D99Q36877056-AA252BD2-3A4C-4E95-86F8-925020E14069Q37729866-D5A6F3B3-23D0-4E37-9B90-D64ABC165E8BQ37860653-0B7A6B19-54FF-4F4D-B5BE-73A6638510A7Q37860655-A1E544D4-46F2-4A18-9C9B-9114F614D115Q38144458-D24F07C9-1004-4B3D-9D0C-AC34882632ABQ38195447-FD4172AB-1A6F-4F46-8EA4-490CD19BB18EQ38347689-A165807E-F8C1-4017-8693-57C12984CC7EQ38665636-0FCE4B03-228D-458A-A99D-349063AF498FQ38665639-35AE7D26-0FC1-49F9-842B-8629BDACDA09Q38732114-61A3EA84-FB96-46E6-847D-A87CD91B9F5DQ38752679-574E5D0B-6711-40A7-B2E5-764CED36211BQ38759338-918B9FB4-2C55-4130-857F-FFEDA5595D94Q38902200-3568FD5B-0DDA-4F90-B42D-2C9B0667C06BQ40513703-8AEA1E5D-255F-4AA3-A9A7-80A3E40CF4B9Q40531381-CF56F5F1-1538-4D43-843B-0DD474BC42B1Q40561776-04D3E3B8-232D-46F1-956E-3BA05FA4B490Q40613015-939CCC2B-E77D-47D5-A60E-5F7E537393F0Q41250384-BA6DECA2-D704-4B3C-B52A-539DF2A0D1C1Q42449053-02029EAC-E882-4150-8C47-8368493A2F38Q42474290-2B0F6C20-4777-442F-960A-1C2FBBD14D9CQ43053507-995740AB-93B6-468C-8370-FFCFAD2A1A6AQ43280375-674A5095-A81C-4E65-A083-C8315F5C1B35Q43464962-22DA2B77-C300-40D2-9B89-FECD5E6193C9Q44321365-D631D58A-2F24-40F6-A3B5-257BABE5A8F6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hwee Teoh
@ast
Hwee Teoh
@en
Hwee Teoh
@es
Hwee Teoh
@nl
Hwee Teoh
@sl
type
label
Hwee Teoh
@ast
Hwee Teoh
@en
Hwee Teoh
@es
Hwee Teoh
@nl
Hwee Teoh
@sl
prefLabel
Hwee Teoh
@ast
Hwee Teoh
@en
Hwee Teoh
@es
Hwee Teoh
@nl
Hwee Teoh
@sl
P106
P1153
7003816542
P31
P496
0000-0003-1036-4767